RESULTS OF PANITUMUMAB ADDITION TO CONVERSION THERAPY FOR COLORECTAL CANCER LIVER METASTASES
Panitumumab has been shown to increase progression free and overall survival in patients with metastatic colorectal cancer.Our purpose was to evaluate whether panitumumab is effective and safe in patients with potentially resectable colorectal liver metastases (CRLM).Methods. Consecutive analysis of...
Main Authors: | M. I. Sekacheva, E. M. Paltseva, N. N. Bagmet, A. L. Bedzhanyan, L. O. Polishchuk, O. G. Skipenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
“ABV-press” Publishing house”, LLC
2015-02-01
|
Series: | Тазовая хирургия и онкология |
Subjects: | |
Online Access: | https://ok.abvpress.ru/jour/article/view/88 |
Similar Items
-
Chemotherapy in combination with resection for colorectal liver metastases – current evidence
by: Maciej Krasnodebski, et al.
Published: (2020-12-01) -
Significant impact of cachexia index on the outcomes after hepatic resection for colorectal liver metastases
by: Yoshiaki Tanji, et al.
Published: (2022-11-01) -
Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
by: Hirofumi Ichida, et al.
Published: (2019-06-01) -
Liver Transplantation for Non-Resectable Colorectal Liver Metastases
by: Ashwin Rammohan
Published: (2018-09-01) -
Simultaneous pure laparoscopic resection of primary colorectal cancer and synchronous liver metastases: a single institution experience with propensity score matching analysis
by: Ivanecz Arpad, et al.
Published: (2017-11-01)